XML 27 R7.htm IDEA: XBRL DOCUMENT v3.10.0.1
Consolidated Statements of Changes in Equity - USD ($)
$ in Thousands
Total
Series A Convertible Preferred Stock [Member]
Common Stock [Member]
Additional Paid-in Capital [Member]
Accumulated Other Comprehensive Income (Loss) [Member]
Accumulated Deficit [Member]
Treasury Stock [Member]
Noncontrolling Interests [Member]
Beginning balances at Dec. 31, 2015 $ 299,756 $ 357 $ 71 $ 381,659 $ (1,174) $ (81,424) $ (96) $ 363
Beginning balances, shares at Dec. 31, 2015   35,759 70,613,642       29,990  
Vesting of restricted stock units, shares     262,474          
Stock-based compensation 4,469     4,469        
Payment of contingent consideration 352     352        
Payment of contingent consideration, shares     35,464          
Issuance of common stock under employee stock purchase plan 433     433        
Issuance of common stock under employee stock purchase plan, shares     48,208          
Conversion of Series A convertible preferred stock to common stock   $ (7)   7        
Conversion of Series A convertible preferred stock to common stock, shares   (708) 1,178          
Exercise of SARs, shares     150,897          
Series A convertible preferred stock dividend   $ 14       (14)    
Series A convertible preferred stock dividend, shares   1,415            
Net loss (23,226)         (23,511)   285
Foreign currency translation adjustments 84       85     (1)
Ending balances at Dec. 31, 2016 281,868 $ 364 $ 71 386,920 (1,089) (104,949) $ (96) 647
Ending balances, shares at Dec. 31, 2016   36,466 71,111,863       29,990  
Vesting of restricted stock units 1   $ 1          
Vesting of restricted stock units, shares     584,261          
Stock-based compensation 5,086     5,086        
Payment of contingent consideration 347     347        
Payment of contingent consideration, shares     40,372          
Issuance of common stock under employee stock purchase plan 1,183     1,183        
Issuance of common stock under employee stock purchase plan, shares     129,838          
Proceeds from offering of common stock 15,000   $ 2 14,998        
Proceeds from offering of common stock, shares     1,552,795          
Issuance of common stock in connection with acquisitions 2,764     2,764        
Issuance of common stock in connection with acquisitions, shares     267,818          
Exercise of SARs, shares     749,632          
Series A convertible preferred stock dividend   $ 12       (12)    
Series A convertible preferred stock dividend, shares   1,078            
Net loss (61,195)         (61,284)   89
Foreign currency translation adjustments 1,342       1,345     (3)
Ending balances at Dec. 31, 2017 246,396 $ 376 $ 74 411,298 256 (166,245) $ (96) 733
Ending balances, shares at Dec. 31, 2017   37,544 74,436,579       29,990  
Vesting of restricted stock units 1   $ 1          
Vesting of restricted stock units, shares     581,013          
Stock-based compensation 8,060     8,060        
Issuance of common stock under employee stock purchase plan 1,194     1,194        
Issuance of common stock under employee stock purchase plan, shares     152,965          
Proceeds from offering of common stock 27,967   $ 3 27,964        
Proceeds from offering of common stock, shares     3,450,000          
Common stock issued as payment for MPUs 827     827        
Common stock issued as payment for MPUs, shares     81,277          
Exercise of SARs 1   $ 1          
Exercise of SARs, shares     306,409          
Series A convertible preferred stock dividend   $ 18       (18)    
Series A convertible preferred stock dividend, shares   1,898            
Net loss (25,939)         (26,244)   305
Foreign currency translation adjustments (649)       (637)     (12)
Ending balances at Dec. 31, 2018 $ 257,858 $ 394 $ 79 $ 449,343 $ (381) $ (192,507) $ (96) $ 1,026
Ending balances, shares at Dec. 31, 2018   39,442 79,008,243       29,990